Renaissance Technologies’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $321K | Buy |
+43,000
| New | +$321K | ﹤0.01% | 3019 |
|
|
2024
Q4 | – | Sell |
-15,800
| Closed | -$99.4K | – | 3797 |
|
|
2024
Q3 | $99.4K | Sell |
15,800
-58,700
| -79% | -$369K | ﹤0.01% | 3259 |
|
|
2024
Q2 | $472K | Buy |
74,500
+12,800
| +21% | +$81K | ﹤0.01% | 2713 |
|
|
2024
Q1 | $506K | Buy |
61,700
+9,900
| +19% | +$81.2K | ﹤0.01% | 2860 |
|
|
2023
Q4 | $432K | Buy |
51,800
+26,400
| +104% | +$220K | ﹤0.01% | 2845 |
|
|
2023
Q3 | $327K | Sell |
25,400
-11,000
| -30% | -$142K | ﹤0.01% | 2890 |
|
|
2023
Q2 | $581K | Buy |
+36,400
| New | +$581K | ﹤0.01% | 2789 |
|